Capital Performance Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7
Closed -$264 376
2024
Q3
$264 Buy
+7
New +$270 ﹤0.01% 2492

Other funds holding ATEX

Capital Performance Advisors's ATEX Position: Q4 2024 in Review

Capital Performance Advisors sold out of Anterix (ATEX) in Q4 2024, closing a stake of 7 shares — an estimated $264 sold.

Capital Performance Advisors first reported a position in ATEX in Q3 2024 and held it in 1 quarter. The position peaked at $264 in Q3 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • Capital Performance Advisors reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 7 Anterix shares in Q4 2024, an estimated $264.
  • Capital Performance Advisors first reported a position in Anterix in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Anterix position peaked at $264 in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.